Biomarin Pharmaceutical Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 452.88M376.27M441.36M500.72M548.49M749.28M889.89M1116.85M1313.65M1491.21M1704.05M1860.45M1846.28M2096.04M2419.23M2853.91M
Cost of Revenue 91.94M70.28M84.02M91.83M88.39M122.27M152.01M209.62M241.79M315.26M359.47M524.27M470.51M503.02M532.06M580.24M
Gross Profit 360.94M305.98M357.33M408.89M460.09M627.02M737.89M907.23M1071.86M1175.95M1344.58M1336.18M1375.76M1593.02M1887.16M2273.68M
Operating items
Amortization - Intangibles 4.06M6.41M1.43M18.72M25.03M23.71M-17.69M-26.95M46.47M48.79M74.11M66.66M69.93M67.19M62.21M43.26M
Research & Development 160.58M147.31M214.37M302.22M354.78M461.54M634.81M661.90M610.75M696.33M715.01M628.12M628.79M649.61M746.77M747.18M
Selling, General & Administrative 173.38M151.72M175.42M198.17M235.36M302.16M402.27M476.59M554.34M604.35M680.92M737.67M759.38M823.24M892.41M1009.02M
Other Operating Expenses 96.00M0.49M0.06M-1.79M0.98M67.50M369.50M4.93M125.00M50.00M25.00M52.82M11.85M108.00M-38.22M10.00M
Operating Expenses 429.96M375.72M475.25M610.94M704.49M842.17M1000.60M1920.28M1328.35M1614.74M1804.51M1903.89M1928.62M1935.07M2233.45M2369.70M
Operating Income 22.91M0.54M-33.89M-110.22M-156.01M-92.89M-110.70M-803.43M-14.70M-123.52M-100.46M-43.44M-82.34M160.97M185.77M484.21M
EBIT 22.91M0.54M-33.89M-110.22M-156.01M-92.89M-110.70M-803.43M-14.70M-123.52M-100.46M-43.44M-82.34M160.97M185.77M484.21M
Non-operating items
Interest & Investment Income 7.09M4.11M2.93M2.58M3.08M5.94M4.50M7.49M14.85M22.83M22.75M16.61M10.48M18.03M58.34M74.88M
Non Operating Income 0.04M154.55M9.40M12.58M
Net income details
EBT 5.20M-50.15M-107.27M-163.70M-176.50M-124.87M-154.72M-831.05M-35.88M-142.71M-94.81M-49.00M-75.35M149.58M188.56M541.76M
Tax Provisions 0.00M-227.31M10.21M5.99M8.76M34.72M93.90M-200.84M81.17M-65.49M-70.96M-903.03M-11.27M8.02M20.92M114.90M
Profit After Tax -5.07M205.82M-53.84M-114.35M-176.35M-133.97M-171.80M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Equity Income -3.62M-2.99M-2.43M-1.22M-1.15M-0.88M-0.82M-0.54M-1.29M-0.55M-0.59M-0.01M
Investment Income 0.01M
Income from Continuing Operations 5.20M177.16M-117.48M-169.69M-185.26M-159.59M-248.63M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Consolidated Net Income 5.20M177.16M-117.48M-169.69M-185.26M-159.59M-248.63M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Income towards Parent Company 5.20M177.16M-117.48M-169.69M-185.26M-159.59M-248.63M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Net Income towards Common Stockholders 5.20M177.16M-117.48M-169.69M-185.26M-159.59M-248.63M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Additional items
EPS (Basic) 0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M0.00M0.00M0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 100.73M102.50M114.21M123.83M142.21M159.14M161.25M172.87M175.62M178.37M179.63M181.53M183.59M185.85M188.37M190.58M
Shares Outstanding (Diluted Average) 139.87M125.67M166.22M174.43M177.27M179.04M191.68M182.85M188.96M191.59M196.71M
EBITDA 22.91M0.54M-33.89M-110.22M-156.01M-92.89M-110.70M-803.43M-14.70M-123.52M-100.46M-43.44M-82.34M160.97M185.77M484.21M
Tax Rate 0.02%24.17%45.89%74.85%14.96%5.36%11.09%21.21%